STAT3 Pathways Contribute to β-HCH Interference with Anticancer Tyrosine Kinase Inhibitors.
Fiorini S, Rubini E, Perugini M, Altieri F, Chichiarelli S, Meschiari G, Arrighetti G, Vijgen J, Natali PG, Minacori M, Eufemi M.
Fiorini S, et al. Among authors: natali pg.
Int J Mol Sci. 2024 Jun 4;25(11):6181. doi: 10.3390/ijms25116181.
Int J Mol Sci. 2024.
PMID: 38892372
Free PMC article.